FALNIDAMOL

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C18H19ClFN7
Molecular Weight	387.842
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of FALNIDAMOL

Structure Search

SMILES

CN1CCC(CC1)NC2=NC3=C(NC4=CC=C(F)C(Cl)=C4)N=CN=C3C=N2

InChI

InChIKey=FTFRZXFNZVCRSK-UHFFFAOYSA-N

InChI=1S/C18H19ClFN7/c1-27-6-4-11(5-7-27)25-18-21-9-15-16(26-18)17(23-10-22-15)24-12-2-3-14(20)13(19)8-12/h2-3,8-11H,4-7H2,1H3,(H,21,25,26)(H,22,23,24)

HIDE SMILES / InChI

Molecular Formula	C18H19ClFN7
Molecular Weight	387.842
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:17:42 UTC 2023` Edited by `admin` on `Fri Dec 15 16:17:42 UTC 2023`
Record UNII	0MU316797D
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FALNIDAMOL

Official Name

English

BIBX1382

Common Name

English

Falnidamol [WHO-DD]

Common Name

English

8-(3-CHLORO-4-FLUOROANILINO)-2-((1-METHYL-4-PIPERIDYL)AMINO)PYRIMIDO(5,4-D)PYRIMIDINE

Systematic Name

English

BIBX-1382

Code

English

falnidamol [INN]

Common Name

English

BIBX 1382

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C2167

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

NCI_THESAURUS

C1967

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

Code System Code Type Description

SMS_ID

100000127711

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

PRIMARY

CAS

196612-93-8

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

PRIMARY

EVMPD

SUB33798

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

PRIMARY

FDA UNII

0MU316797D

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

PRIMARY

INN

7857

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

PRIMARY

DRUG BANK

DB12966

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

PRIMARY

PUBCHEM

6918508

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

PRIMARY

NCI_THESAURUS

C80868

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

PRIMARY

ChEMBL

CHEMBL258940

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

PRIMARY

EPA CompTox

DTXSID0048399

Created by admin on Fri Dec 15 16:17:42 UTC 2023 , Edited by admin on Fri Dec 15 16:17:42 UTC 2023

PRIMARY

Related Record Type Details


					LR0F81F33L

ALDEHYDE OXIDASE

METABOLIC ENZYME -> SUBSTRATE

Comments:

Failed due to undetected hAOX-mediated oxidation.


					RO03J093CP

EPIDERMAL GROWTH FACTOR RECEPTOR

TARGET -> INHIBITOR

Related Record Type Details


					0MU316797D

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Volume of Distribution	PHARMACOKINETIC

Biological Half-life	PHARMACOKINETIC